| Secondary |
| Product Used For Unknown Indication |
30.4% |
| Brief Psychotic Disorder With Marked Stressors |
21.4% |
| Drug Use For Unknown Indication |
13.2% |
| Psychotic Disorder |
6.7% |
| Autism |
4.0% |
| Mental Disorder |
3.1% |
| Schizophrenia |
2.8% |
| Insomnia |
2.3% |
| Agitation |
2.1% |
| Anxiety |
1.8% |
| Abnormal Behaviour |
1.5% |
| Breast Cancer |
1.5% |
| Schizophrenia, Paranoid Type |
1.5% |
| Foetal Exposure During Pregnancy |
1.3% |
| Psychiatric Decompensation |
1.3% |
| Depression |
1.0% |
| Hypertension |
1.0% |
| Psychiatric Symptom |
1.0% |
| Bipolar Disorder |
0.9% |
| Postoperative Care |
0.9% |
|
| Somnolence |
10.5% |
| Vomiting |
8.1% |
| Off Label Use |
7.3% |
| Skin Lesion |
7.3% |
| Tachycardia |
7.3% |
| Urinary Retention |
6.5% |
| Catatonia |
5.6% |
| Coma |
5.6% |
| Suicide Attempt |
4.8% |
| Hypoglycaemia |
4.0% |
| Pneumonia Aspiration |
4.0% |
| Pulmonary Embolism |
4.0% |
| Sepsis |
4.0% |
| Left Ventricular Failure |
3.2% |
| Parkinsonism |
3.2% |
| Renal Failure Acute |
3.2% |
| Thrombocytopenia |
3.2% |
| Weight Decreased |
3.2% |
| Dyskinesia |
2.4% |
| Neuroleptic Malignant Syndrome |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
15.4% |
| Schizophrenia |
14.5% |
| Drug Use For Unknown Indication |
13.1% |
| Psychotic Disorder |
11.6% |
| Agitation |
9.3% |
| Central Nervous System Lymphoma |
5.4% |
| Anxiety |
3.7% |
| Epilepsy |
3.3% |
| Depression |
3.1% |
| Anaesthesia |
2.5% |
| Bipolar I Disorder |
2.3% |
| Bipolar Disorder |
2.1% |
| Mania |
2.1% |
| Transplant |
2.1% |
| Abnormal Behaviour |
1.7% |
| Brief Psychotic Disorder With Marked Stressors |
1.7% |
| Hepatitis C |
1.7% |
| Unevaluable Event |
1.7% |
| Delirium |
1.5% |
| Persecutory Delusion |
1.5% |
|
| Pulmonary Embolism |
13.7% |
| Rhabdomyolysis |
11.6% |
| Suicide Attempt |
6.3% |
| Miosis |
5.3% |
| Neutropenia |
5.3% |
| Pancreatitis Acute |
5.3% |
| Prescribed Overdose |
5.3% |
| Torsade De Pointes |
5.3% |
| Treatment Noncompliance |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
| Death |
4.2% |
| Vitamin B6 Deficiency |
4.2% |
| Hyporeflexia |
3.2% |
| Hypotension |
3.2% |
| Renal Failure |
3.2% |
| Somnolence |
3.2% |
| Tricuspid Valve Incompetence |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Delirium |
2.1% |
| Gastrointestinal Necrosis |
2.1% |
|
| Interacting |
| Drug Use For Unknown Indication |
56.7% |
| Agitation |
10.0% |
| Bipolar Disorder |
10.0% |
| Insomnia |
10.0% |
| Bipolar I Disorder |
6.7% |
| Product Used For Unknown Indication |
6.7% |
|
| Tremor |
36.4% |
| Insomnia |
18.2% |
| Sudden Death |
18.2% |
| Drug Interaction |
9.1% |
| Parkinsonism |
9.1% |
| Shock |
9.1% |
|
